Diatos is a biopharmaceutical company developing innovative therapies for unmet medical needs in cancer.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Paris
State: Ile-de-France
Zip:
Country: France
Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and drug candidates through a strategy of license acquisitions as well as an internal research and development activity based on its prodrug technologies, Vectocell® and Tumor-Selective Prodrug (TSP).
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2007 | Series D | 10 | $12.8M |
Biotech Fund Flanders Credit Agricole Entreprises Gimv Idinvest Partners Innoven Partners InterWest Partners NIF SMBC Ventures Societe Generale Asset Management Sofinnova Partners Sopartec Biotech Fund Flanders Credit Agricole Entreprises Gimv Idinvest Partners Innoven Partners InterWest Partners NIF SMBC Ventures Societe Generale Asset Management Sofinnova Partners Sopartec |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|